James A. Yergey - Concepedia

Author

James A. Yergey

Also Known As

J A Yergey, J A. Yergey, J Yergey, J. A. YERGEY, J. A. Yergey, J. YERGEY, J. Yergey, J.A. Yergey, JAMES A. YERGEY, JAMES YERGEY

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Merck Canada Inc. (Canada)Johns Hopkins University United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Johns Hopkins Medicine

About

James A. Yergey is an author at Merck Canada Inc. (Canada) specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	26	1.1K
2	Engineering	12	13	611
3	Natural Sciences	12	13	748
4	Health Sciences	1	1	10
5	Public Health	1	1	73

James A. Yergey

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status Melvyn P. Heyes, Bruce J. Brew, Alex Martin, Annals of Neurology	1991	570
Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. Denis Riendeau, Jocelyne Guay, P K Weech, Journal of Biological Chemistry	1994	258
A general approach to calculating isotopic distributions for mass spectrometry James A. Yergey International Journal of Mass Spectrometry and Ion Physics Mass SpectrometryBiostatisticsAnalytical ChemistryChemistryComputational Mass Spectrometry	1983	219
Isotopic distributions in mass spectra of large molecules James A. Yergey, David N. Heller, G.E. Hansen, Analytical Chemistry Molecular SciencesEngineeringBiochemistryNatural SciencesSpectroscopy	1983	201
Description of a 96-Well Plate Assay to Measure Cytochrome P4503A Inhibition in Human Liver Microsomes Using a Selective Fluorescent Probe Nathalie Chauret, Nathalie Tremblay, Rebecca L. Lackman, Analytical Biochemistry Molecular PharmacologyBiochemistryMedicineLiver PhysiologyBioanalysis	1999	96
Refinement of an in vitro cell model for cytochrome P450 induction. José M. Silva, Pierre-Emmanuel Morin, Stephen H. Day, PubMed Vitro Cell ModelCellular PharmacologyPharmacotherapyExperimental PharmacologyPhysiologically-based Pharmacokinetic Modeling	1998	89
Purification and Characterization of Recombinant Human Cyclooxygenase-2 M. David Percival, Marc Ouellet, C. Vincent, Archives of Biochemistry and Biophysics Cellular EnzymologyBiosynthesisRecombinant Human Cyclooxygenase-2Biochemistry	1994	76
Chemical characterization of organic adsorbates on diesel particulate matter James A. Yergey, Terence H. Risby, S. S. Lestz Analytical Chemistry Samuel S. LestzciteEnvironmental ChemistryChemical EngineeringEngineeringPersistent Organic Pollutant	1982	73
Diversity in the Oxidation of Substrates by Cytochrome P450 2D6: Lack of an Obligatory Role of Aspartate 301−Substrate Electrostatic Bonding F. Peter Guengerich, Grover P. Miller, Imad Hanna, Biochemistry Drug TargetBioelectrochemistrySpirosulfonamide AnaloguesChemistryCytochrome P450 2D6	2002	62
Quinolinic Acid Concentrations in Brain and Cerebrospinal Fluid of Patients with Intractable Complex Partial Seizures Melvyn P. Heyes, Allen R. Wyler, Orrin Devinsky, Epilepsia	1990	62

Page 1